During the past decade, University of Alabama MS Center-Site Number:8400013 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Alabama MS Center-Site Number:8400013" are "Relapsing Multiple Sclerosis" (1 trials) and "Secondary Progressive Multiple Sclerosis" (1 trials). Many other conditions were trialed in "University of Alabama MS Center-Site Number:8400013" in a lesser frequency.

Most popular intervention types in "University of Alabama MS Center-Site Number:8400013" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo to match Tolebrutinib" (2 trials), "Tolebrutinib" (2 trials), "Placebo to match Teriflunomide" (1 trials) and "Teriflunomide HMR1726" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Alabama MS Center-Site Number:8400013" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Alabama MS Center-Site Number:8400013". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University of Alabama MS Center-Site Number:8400013, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Alabama MS Center-Site Number:8400013, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".